Literature DB >> 2991561

Identification of a herpes simplex virus function that represses late gene expression from parental viral genomes.

P J Godowski, D M Knipe.   

Abstract

The expression of herpes simplex virus gamma 2 (late) genes is inhibited before the onset of viral DNA replication. We report that the block in the expression of certain gamma 2 genes is relieved, at least in part, by defects in the beta ICP8 protein. We have examined the expression of the gamma 2 gene encoding glycoprotein C (gC) in cells infected with a temperature-sensitive ICP8 mutant. Under conditions in which viral DNA replication is inhibited, cells infected with the ICP8 mutant overproduce the gC family of mRNAs relative to the level observed in cells infected with a wild-type virus. The gC mRNA synthesized in cells infected with the ICP8 mutant virus is correctly initiated and spliced and is translated with the same relative efficiency as in cells infected with a replicating wild-type virus. These results suggest that ICP8 is involved in the negative regulation of gamma 2 genes expressed from parental viral genomes. The level of gC expression was greatest in cells infected with a replicating wild-type virus. These data suggest that DNA replication and genome amplification are not absolute requirements for gamma 2 gene expression but may facilitate full-level expression of these genes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991561      PMCID: PMC254941     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Anatomy of herpes simplex virus DNA VIII. Properties of the replicating DNA.

Authors:  R J Jacob; B Roizman
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

2.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Molecular genetics of herpes simplex virus. III. Fine mapping of a genetic locus determining resistance to phosphonoacetate by two methods of marker transfer.

Authors:  D M Knipe; W T Ruyechan; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

5.  Complex splicing patterns of RNAs from the early regions of adenovirus-2.

Authors:  L T Chow; T R Broker; J B Lewis
Journal:  J Mol Biol       Date:  1979-10-25       Impact factor: 5.469

6.  A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis.

Authors:  R J Watson; J B Clements
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

7.  Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species.

Authors:  L E Holland; K P Anderson; C Shipman; E K Wagner
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

8.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

9.  Synthesis and processing of glycoproteins gD and gC of herpes simplex virus type 1.

Authors:  G H Cohen; D Long; R J Eisenberg
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

10.  Regulation of early adenovirus transcription: a protein product of early region 2 specifically represses region 4 transcription.

Authors:  J R Nevins; J J Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

View more
  37 in total

1.  Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein.

Authors:  M Gao; D M Knipe
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

2.  A dominant-negative herpesvirus protein inhibits intranuclear targeting of viral proteins: effects on DNA replication and late gene expression.

Authors:  E E McNamee; T J Taylor; D M Knipe
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Surface lysine and tyrosine residues are required for interaction of the major herpes simplex virus type 1 DNA-binding protein with single-stranded DNA.

Authors:  W T Ruyechan; J W Olson
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Conservation of gene organization in the lymphotropic herpesviruses herpesvirus Saimiri and Epstein-Barr virus.

Authors:  U A Gompels; M A Craxton; R W Honess
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses.

Authors:  M Kosz-Vnenchak; D M Coen; D M Knipe
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27.

Authors:  S A Rice; D M Knipe
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes.

Authors:  S L Uprichard; D M Knipe
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Association of herpes simplex virus regulatory protein ICP22 with transcriptional complexes containing EAP, ICP4, RNA polymerase II, and viral DNA requires posttranslational modification by the U(L)13 proteinkinase.

Authors:  R Leopardi; P L Ward; W O Ogle; B Roizman
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Functional mapping of Autographa california nuclear polyhedrosis virus genes required for late gene expression.

Authors:  L A Guarino; M D Summers
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

10.  Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype.

Authors:  P A Johnson; M G Best; T Friedmann; D S Parris
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.